BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35182598)

  • 1. European interlaboratory comparison investigations (ICI) and external quality assurance schemes (EQUAS) for the analysis of bisphenol A, S and F in human urine: Results from the HBM4EU project.
    Vaccher V; Lopez ME; Castaño A; Mol H; Haji-Abbas-Zarrabi K; Bury D; Koch HM; Dvorakova D; Hajslova J; Nübler S; Kaur Sakhi A; Thomsen C; Vorkamp K; Göen T; Antignac JP
    Environ Res; 2022 Jul; 210():112933. PubMed ID: 35182598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interlaboratory comparison investigations (ICIs) and external quality assurance schemes (EQUASs) for flame retardant analysis in biological matrices: Results from the HBM4EU project.
    Dvorakova D; Pulkrabova J; Gramblicka T; Polachova A; Buresova M; López ME; Castaño A; Nübler S; Haji-Abbas-Zarrabi K; Klausner N; Göen T; Mol H; Koch HM; Vaccher V; Antignac JP; Haug LS; Vorkamp K; Hajslova J
    Environ Res; 2021 Nov; 202():111705. PubMed ID: 34297934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interlaboratory comparison investigations (ICI) and external quality assurance schemes (EQUAS) for cadmium in urine and blood: Results from the HBM4EU project.
    Nübler S; López ME; Castaño A; Mol H; Schäfer M; Haji-Abbas-Zarrabi K; Bury D; Koch HM; Vaccher V; Antignac JP; Dvorakova D; Hajslova J; Thomsen C; Vorkamp K; Göen T
    Int J Hyg Environ Health; 2021 May; 234():113711. PubMed ID: 33714064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Quality Assurance Schemes (EQUASs) and Inter-laboratory Comparison Investigations (ICIs) for human biomonitoring of polycyclic aromatic hydrocarbon (PAH) biomarkers in urine as part of the quality assurance programme under HBM4EU.
    Nübler S; Esteban López M; Castaño A; Mol HGJ; Müller J; Schäfer M; Haji-Abbas-Zarrabi K; Hajslova J; Pulkrabova J; Dvorakova D; Urbancova K; Koch HM; Antignac JP; Sakhi AK; Vorkamp K; Burkhardt T; Scherer M; Göen T
    Int J Hyg Environ Health; 2023 May; 250():114169. PubMed ID: 37099846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interlaboratory Comparison Investigations (ICIs) and External Quality Assurance Schemes (EQUASs) for human biomonitoring of perfluoroalkyl substances (PFASs) in serum as part of the quality assurance programme under HBM4EU.
    Nübler S; Esteban López M; Castaño A; Mol HGJ; Haji-Abbas-Zarrabi K; Schäfer M; Müller J; Hajslova J; Dvorakova D; Antignac JP; Koch HM; Haug LS; Vorkamp K; Göen T
    Sci Total Environ; 2022 Nov; 847():157481. PubMed ID: 35868372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The European human biomonitoring platform - Design and implementation of a laboratory quality assurance/quality control (QA/QC) programme for selected priority chemicals.
    Esteban López M; Göen T; Mol H; Nübler S; Haji-Abbas-Zarrabi K; Koch HM; Kasper-Sonnenberg M; Dvorakova D; Hajslova J; Antignac JP; Vaccher V; Elbers I; Thomsen C; Vorkamp K; Pedraza-Díaz S; Kolossa-Gehring M; Castaño A
    Int J Hyg Environ Health; 2021 May; 234():113740. PubMed ID: 33774419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for bisphenol A.
    Ougier E; Zeman F; Antignac JP; Rousselle C; Lange R; Kolossa-Gehring M; Apel P
    Environ Int; 2021 Sep; 154():106563. PubMed ID: 33894553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interlaboratory Comparison Investigations (ICIs) for human biomonitoring of chromium as part of the quality assurance programme under HBM4EU.
    Nübler S; Schäfer M; Haji-Abbas-Zarrabi K; Marković S; Marković K; Esteban López M; Castaño A; Mol H; Koch HM; Antignac JP; Hajslova J; Thomsen C; Vorkamp K; Göen T
    J Trace Elem Med Biol; 2022 Mar; 70():126912. PubMed ID: 34954563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomonitoring of occupational exposure to bisphenol A, bisphenol S and bisphenol F: A systematic review.
    Bousoumah R; Leso V; Iavicoli I; Huuskonen P; Viegas S; Porras SP; Santonen T; Frery N; Robert A; Ndaw S
    Sci Total Environ; 2021 Aug; 783():146905. PubMed ID: 33865140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proficiency and Interlaboratory Variability in the Determination of Phthalate and DINCH Biomarkers in Human Urine: Results from the HBM4EU Project.
    Mol HGJ; Elbers I; Pälmke C; Bury D; Göen T; López ME; Nübler S; Vaccher V; Antignac JP; Dvořáková D; Hajšlová J; Sakhi AK; Thomsen C; Vorkamp K; Castaño A; Koch HM
    Toxics; 2022 Jan; 10(2):. PubMed ID: 35202244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EuroMix human biomonitoring study: Source-to-dose modeling of cumulative and aggregate exposure for the bisphenols BPA, BPS, and BPF and comparison with measured urinary levels.
    Karrer C; Andreassen M; von Goetz N; Sonnet F; Sakhi AK; Hungerbühler K; Dirven H; Husøy T
    Environ Int; 2020 Mar; 136():105397. PubMed ID: 31884417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The European COPHES/DEMOCOPHES project: towards transnational comparability and reliability of human biomonitoring results.
    Schindler BK; Esteban M; Koch HM; Castano A; Koslitz S; Cañas A; Casteleyn L; Kolossa-Gehring M; Schwedler G; Schoeters G; Hond ED; Sepai O; Exley K; Bloemen L; Horvat M; Knudsen LE; Joas A; Joas R; Biot P; Aerts D; Lopez A; Huetos O; Katsonouri A; Maurer-Chronakis K; Kasparova L; Vrbík K; Rudnai P; Naray M; Guignard C; Fischer ME; Ligocka D; Janasik B; Reis MF; Namorado S; Pop C; Dumitrascu I; Halzlova K; Fabianova E; Mazej D; Tratnik JS; Berglund M; Jönsson B; Lehmann A; Crettaz P; Frederiksen H; Nielsen F; McGrath H; Nesbitt I; De Cremer K; Vanermen G; Koppen G; Wilhelm M; Becker K; Angerer J
    Int J Hyg Environ Health; 2014 Jul; 217(6):653-61. PubMed ID: 24405937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary levels of bisphenol A, F and S and markers of oxidative stress among healthy adult men: Variability and association analysis.
    Wang YX; Liu C; Shen Y; Wang Q; Pan A; Yang P; Chen YJ; Deng YL; Lu Q; Cheng LM; Miao XP; Xu SQ; Lu WQ; Zeng Q
    Environ Int; 2019 Feb; 123():301-309. PubMed ID: 30553203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure and dietary sources of bisphenol A (BPA) and BPA-alternatives among mothers in the APrON cohort study.
    Liu J; Wattar N; Field CJ; Dinu I; Dewey D; Martin JW;
    Environ Int; 2018 Oct; 119():319-326. PubMed ID: 29990952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term variability of bisphenols in spot, morning void and 24-hour urine samples.
    Gys C; Bastiaensen M; Malarvannan G; Ait Bamai Y; Araki A; Covaci A
    Environ Pollut; 2021 Jan; 268(Pt A):115747. PubMed ID: 33012567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internal exposure of Chinese children from a typical coastal city to bisphenols and possible association with thyroid hormone levels.
    Guo C; Ren F; Jin J; Zhang H; Wang L; Zhang H; Chen J
    Environ Int; 2021 Nov; 156():106759. PubMed ID: 34265627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated on-line column-switching high performance liquid chromatography isotope dilution tandem mass spectrometry method for the quantification of bisphenol A, bisphenol F, bisphenol S, and 11 other phenols in urine.
    Zhou X; Kramer JP; Calafat AM; Ye X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():152-6. PubMed ID: 24316527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale biomonitoring of bisphenol analogues and their metabolites in human urine from Guangzhou, China: Implications for health risk assessment.
    Wang H; Gao R; Liang W; Wei S; Zhou Y; Wang Z; Lan L; Chen J; Zeng F
    Chemosphere; 2023 Oct; 338():139601. PubMed ID: 37480947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordination of chemical analyses under the European Human Biomonitoring Initiative (HBM4EU): Concepts, procedures and lessons learnt.
    Vorkamp K; Esteban López M; Gilles L; Göen T; Govarts E; Hajeb P; Katsonouri A; Knudsen LE; Kolossa-Gehring M; Lindh C; Nübler S; Pedraza-Díaz S; Santonen T; Castaño A
    Int J Hyg Environ Health; 2023 Jun; 251():114183. PubMed ID: 37148759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes.
    Karrer C; Roiss T; von Goetz N; Gramec Skledar D; Peterlin Mašič L; Hungerbühler K
    Environ Health Perspect; 2018 Jul; 126(7):077002. PubMed ID: 29995627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.